CJC-1295 without DAC 2 mg

A synthetic modified peptide molecule called CJC-1295 lacking DAC was created for use in lab studies. Due to the absence of the Drug Affinity Complex (DAC) alteration, this molecular form exhibits distinct stability properties under experimental settings. In vitro investigations have demonstrated the compound’s selective receptor binding characteristics due to its finely tailored 29-amino acid sequence structure. This version is especially well-suited for some kinds of acute laboratory experiments and molecular signaling study because it exhibits distinct pharmacokinetic characteristics in solution when compared to its DAC-modified counterpart.